| Literature DB >> 24927662 |
Shalom Patole1, Sakib Burza2, George M Varghese3.
Abstract
Visceral Leishmaniasis (VL) is an opportunistic infection amongst HIV-infected people in several endemic countries, and the clinical management of this co-infection poses several challenges. Here we describe a co-infected patient in India who failed to respond to miltefosine monotherapy and subsequently relapsed following two further (different) regimens of liposomal amphotericin B. He was then successfully treated with a combination of 30 mg/kg liposomal amphotericin B and 14 days of 100mg/day oral miltefosine.Entities:
Keywords: HIV infection; Relapse; Treatment; Visceral leishmaniasis
Mesh：
Substances：
Year: 2014 PMID： 24927662 DOI： 10.1016/j.ijid.2014.02.015
Source DB: PubMed Journal: Int J Infect Dis ISSN： 1201-9712 Impact factor: 3.623